Nocturnal symptoms and sleep disturbances in clinically stable asthmatic children

Inder Mohan Chugh1, Puneet Khanna, Ashok Shah

  • 1Department of Respiratory Medicine, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.

Insights

Asthmatic children experience frequent nocturnal symptoms and sleep disturbances, impacting their daytime activity. Awareness of the asthma-sleep connection is crucial for better asthma management in children.

Area of Science:

  • Pediatric Pulmonology
  • Sleep Medicine
  • Asthma Research

Background:

  • Nocturnal symptoms are linked to asthma severity.
  • Even clinically stable asthmatic children report sleep disturbances.
  • Understanding these issues in a home environment is important.

Purpose of the Study:

  • To determine the prevalence of nocturnal symptoms and sleep disturbances in stable, school-going asthmatic children.
  • To compare these parameters with age and gender-matched healthy children.
  • To assess the impact of environmental tobacco smoke exposure.

Main Methods:

  • A case-control, questionnaire-based study involving 70 children (40 asthmatics, 30 healthy controls).
  • Parents maintained daily sleep diaries and recorded peak expiratory flow (PEF) for one week.
  • Utilized validated scales to assess sleep quality and daytime function.

Main Results:

  • Asthmatic children showed significantly lower mean morning and evening PEF values.
  • A high percentage of asthmatic children reported nocturnal symptoms (cough, breathlessness, wheeze, chest tightness).
  • Asthmatic children experienced significantly more sleep disturbances, including daytime sleepiness, tiredness, and difficulty maintaining sleep, along with poorer sleep quality and daytime fitness.

Conclusions:

  • Clinically stable asthmatic children exhibit increased nocturnal symptoms and sleep disturbances, leading to poorer sleep quality.
  • There is a lack of awareness regarding the association between asthma and sleep, potentially leading to suboptimal asthma control.
  • Addressing sleep issues is vital for improving overall health and daytime functioning in pediatric asthma patients.

Related Concept Videos

Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Nightmares and Night Terrors01:18

Nightmares and Night Terrors

Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares often...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...